PolyPid (PolyPid) Price-to-Tangible-Book : (As of Apr. 30, 2024)

View and export this data going back to 2020. Start your Free Trial

What is PolyPid Price-to-Tangible-Book?

As of today (2024-04-30), PolyPid's share price is $4.7721. PolyPid's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-1.27. Hence, PolyPid's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for PolyPid's Price-to-Tangible-Book or its related term are showing as below:

During the past 10 years, PolyPid's highest Price to Tangible Book Ratio was 2.99. The lowest was 2.38. And the median was 2.52.

PYPD's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.69
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, PolyPid's share price is $4.7721. PolyPid's Book Value per Sharefor the quarter that ended in Dec. 2023 was $-1.27. Hence, PolyPid's P/B Ratio of today is .

PolyPid Price-to-Tangible-Book Historical Data

The historical data trend for PolyPid's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPid Price-to-Tangible-Book Chart

PolyPid Annual Data

Trend

Dec12

Dec13

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.52

2.99

2.38

PolyPid Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.38	1.56	2.14	2.11	-

Competitive Comparison of PolyPid's Price-to-Tangible-Book

For the Biotechnology subindustry, PolyPid's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PolyPid's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PolyPid's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where PolyPid's Price-to-Tangible-Book falls into.

PolyPid Price-to-Tangible-Book Calculation

PolyPid's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	4.7721	/	-1.268
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

PolyPid Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of PolyPid's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

PolyPid (PolyPid) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PolyPid Ltd (NAS:PYPD) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Hasivim Street, P.O Box 7126, Petach Tikva, ISR, 495376

Website

https://www.polypid.com

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, and Bacyssio are trademarks of the company. The company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies.